PTEN and prostate carcinoma: Therefore, the initial objective of this study was to establish the existence of interplay between tumor-derived CXCL8 from PTEN-deficient prostate cancer cells and the potentiation of stromal-derived CCL2 and CXCL12 expression and/or signaling.